Nasdaq

Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection ...

Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) is the first and only canine oral parasiticide to protect against six parasites, including fleas, ticks, ...
Seeking Alpha

Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest[i] Parasite Protection of Its Kind

"Today is a historic day as we bring veterinarians and pet owners peace of mind with the broadest i parasite protection of its kind for dogs," said Bobby Modi, Executive Vice President, U.S. Pet ...
FiercePharma

Elanco Expands Parasiticide Portfolio in US with New Product for Heartworm Disease, Intestinal Parasites

GREENFIELD, Ind., Oct. 28, 2015 /PRNewswire/ -- Elanco Animal Health has launched Interceptor® Plus (milbemycin oxime/praziquantel) in the United States. Interceptor Plus is a monthly chewable tablet ...
Morningstar

Silent & Spreading: The Tapeworm Story Every Pet Owner Needs To Hear

Dr. Kelly's experience underscores a critical message for all pet owners: the real threat of Echinococcus. According to a survey by Elanco Animal Health, almost half of dog owners don't realize that ...
Seeking Alpha

Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection ...

GREENFIELD, Ind., Oct. 7, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Credelio Quattro™ (lotilaner, ...